An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

[HTML][HTML] Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

F Heidary, R Gharebaghi - The Journal of antibiotics, 2020 - nature.com
Ivermectin proposes many potentials effects to treat a range of diseases, with its
antimicrobial, antiviral, and anti-cancer properties as a wonder drug. It is highly effective …

[HTML][HTML] Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19: a randomized clinical trial

E López-Medina, P López, IC Hurtado, DM Dávalos… - Jama, 2021 - jamanetwork.com
Importance Ivermectin is widely prescribed as a potential treatment for COVID-19 despite
uncertainty about its clinical benefit. Objective To determine whether ivermectin is an …

[HTML][HTML] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

L Caly, JD Druce, MG Catton, DA Jans, KM Wagstaff - Antiviral research, 2020 - Elsevier
Although several clinical trials are now underway to test possible therapies, the worldwide
response to the COVID-19 outbreak has been largely limited to monitoring/containment. We …

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

SNY Yang, SC Atkinson, C Wang, A Lee… - Antiviral research, 2020 - Elsevier
Infection by RNA viruses such as human immunodeficiency virus (HIV)-1, influenza, and
dengue virus (DENV) represent a major burden for human health worldwide. Although RNA …

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo …

C Chaccour, A Casellas, A Blanco-Di Matteo… - …, 2021 - thelancet.com
Background Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not
readily achievable with currently approved doses. There is limited evidence to support its …

[HTML][HTML] Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19

P Kory, GU Meduri, J Varon, J Iglesias… - American journal of …, 2021 - journals.lww.com
Background: After COVID-19 emerged on US shores, providers began reviewing the
emerging basic science, translational, and clinical data to identify potentially effective …

[HTML][HTML] Ivermectin and COVID-19: kee** rigor in times of urgency

C Chaccour, F Hammann… - The American journal …, 2020 - ncbi.nlm.nih.gov
Ivermectin is a widely used drug for the treatment and control of several neglected tropical
diseases. 1 The drug has an excellent safety profile, with more than 2.5 billion doses …

Avermectin derivatives, pharmacokinetics, therapeutic and toxic dosages, mechanism of action, and their biological effects

G El-Saber Batiha, A Alqahtani, OB Ilesanmi, AA Saati… - Pharmaceuticals, 2020 - mdpi.com
Avermectins are a group of drugs that occurs naturally as a product of fermenting
Streptomyces avermitilis, an actinomycetes, isolated from the soil. Eight different structures …

Ivermectin: an anthelmintic, an insecticide, and much more

RJ Martin, AP Robertson, S Choudhary - Trends in parasitology, 2021 - cell.com
Here we tell the story of ivermectin, describing its anthelmintic and insecticidal actions and
recent studies that have sought to reposition ivermectin for the treatment of other diseases …